Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
Capolunghi F, Rosado MM, Cascioli S, Girolami E, Bordasco S, Vivarelli M, Ruggiero B, Cortis E, Insalaco A, Fantò N, Gallo G, Nucera E, Loiarro M, Sette C, De Santis R, Carsetti R, Ruggiero V.
Capolunghi F, et al. Among authors: cascioli s.
Rheumatology (Oxford). 2010 Dec;49(12):2281-9. doi: 10.1093/rheumatology/keq226. Epub 2010 Aug 25.
Rheumatology (Oxford). 2010.
PMID: 20739362